Blood Plasma Derivatives Market Research Report - Forecast till 2030

Blood Plasma Derivatives Market Research Report: Information by Type [Factor VIII Concentrate, Factor IX Concentrate, Albumin, Immune Globulins, Anti-Thrombin III Concentrate, and Fresh Frozen Plasma (FFP)], Application (HIV, Hemophilia A, Hemophilia B, Hepatitis B, Hepatitis C, Bleeding Disorders, Hypogammaglobulinemia, Immunodeficiency Diseases, and Others), End User (Hospitals & Clinics, Blood Transfusion Centers, Diagnostic Centers, and Others), and Region (Americas, Europe, Asia-Pacific, and Middle East & Africa)—Forecast till 2030

ID: MRFR/Pharma/0817-HCR | January 2023 | Region: Global | 80 Pages         

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Overview

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

Chapter 6. Global Blood Plasma Derivatives Market, by Type

6.1 Overview

6.2 Factor VIII Concentrate

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Factor IX Concentrate

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4 Albumin

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5 Immune Globulins

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.6 Anti-Thrombin III Concentrate

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.7 Fresh Frozen Plasma (FFP)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7 Global Blood Plasma Derivatives Market, by Application

7.1 Overview

7.2 HIV

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Hemophilia A

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 Hemophilia B

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5 Hepatitis B

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.6 Hepatitis C

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.7 Bleeding disorders

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.8 Hypogammaglobulinemia

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.9 Immunodeficiency Diseases

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.10 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8 Global Blood Plasma Derivatives Market, by End User

8.1 Overview

8.2 Hospitals & Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Blood Transfusion Centers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Diagnostic Centers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.5 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 10. Global Blood Plasma Derivatives Market, by Region

10.1 Overview

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 Latin America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Overview

11.2 Competitive Analysis

Chapter 12. Company Profile

12.1 Baxter BioScience

12.1.1 Company Overview

12.1.2 Product Type Overview

12.1.3 Financial Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 Grifols S.A.

12.2.1 Company Overview

12.2.2 Product Type Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 CSL Behring

12.3.1 Company Overview

12.3.2 Product Type Overview

12.3.3 Financial Overview

12.3.4 Key Developments

12.3.5 SWOT Analysis

12.4 ViroPharma, Inc.

12.4.1 Company Overview

12.4.2 Product Type Overview

12.4.3 Financial Overview

12.4.4 Key Developments

12.4.5 SWOT Analysis

12.5 Talecris Biotherapeutics, Inc.

12.5.1 Company Overview

12.5.2 Product Type Overview

12.5.3 Financial Overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Octapharma

12.6.1 Company Overview

12.6.2 Product Type Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Fusion Healthcare

12.7.1 Overview

12.7.2 Product Type Overview

12.7.3 Financial Overview

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 SK Plasma Co., Ltd.

12.8.1 Overview

12.8.2 Product Type Overview

12.8.3 Financial Overview

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Biotest AG

12.9.1 Overview

12.9.2 Product Type Overview

12.9.3 Financial Overview

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 Green Cross Corporation

12.10.1 Overview

12.10.2 Product Type Overview

12.10.3 Financial Overview

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Shire Plc

12.11.1 Overview

12.11.2 Product Type Overview

12.11.3 Financial Overview

12.11.4 Key Developments

12.11.5 SWOT Analysis

12.13 Others

Chapter 13 Appendix

13.1 References

13.2 Related Reports

LIST OF TABLES

Table 1 Global Blood Plasma Derivatives Market Synopsis, 2020-2027

Table 2 Global Blood Plasma Derivatives Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Blood Plasma Derivatives Market, by Type, 2020-2027 (USD Million)

Table 4 Global Blood Plasma Derivatives Market, by Applications, 2020-2027 (USD Million)

Table 5 Global Blood Plasma Derivatives Market, by End users, 2020-2027 (USD Million)

Table 6 Global Blood Plasma Derivatives Market, by Region, 2020-2027 (USD Million)

Table 7 North America: Blood Plasma Derivatives Market, by Type, 2020-2027 (USD

Table 8 North America: Blood Plasma Derivatives Market, by Applications, 2020-2027 (USD

Table 9 North America: Blood Plasma Derivatives Market, by End users, 2020-2027 (USD

Table 10 US: Blood Plasma Derivatives Market, by Type, 2020-2027 (USD Million)

Table 11 US: Blood Plasma Derivatives Market, by Applications, 2020-2027 (USD Million)

Table 12 US: Blood Plasma Derivatives Market, by End users, 2020-2027 (USD Million)

Table 13 Canada: Blood Plasma Derivatives Market, by Type, 2020-2027 (USD Million)

Table 14 Canada: Blood Plasma Derivatives Market, by Applications, 2020-2027 (USD Million)

Table 15 Canada: Blood Plasma Derivatives Market, by End users, 2020-2027 (USD Million)

Table 16 Latin America: Blood Plasma Derivatives Market, by Type, 2020-2027 (USD Million)

Table 17 Latin America: Blood Plasma Derivatives Market, by Applications, 2020-2027 (USD Million)

Table 18 Latin America: Blood Plasma Derivatives Market, by End users, 2020-2027 (USD Million)

Table 19 Europe: Blood Plasma Derivatives Market, by Type, 2020-2027 (USD Million)

Table 20 Europe: Blood Plasma Derivatives Market, by Applications, 2020-2027 (USD Million)

Table 21 Europe: Blood Plasma Derivatives Market, by End users, 2020-2027 (USD Million)

Table 22 Western Europe: Blood Plasma Derivatives Market, by Type, 2020-2027 (USD Million)

Table 23 Western Europe: Blood Plasma Derivatives Market, by Applications, 2020-2027 (USD Million)

Table 24 Western Europe: Blood Plasma Derivatives Market, by End users, 2020-2027 (USD Million)

Table 25 Eastern Europe: Blood Plasma Derivatives Market, by Type, 2020-2027 (USD Million)

Table 26 Eastern Europe: Blood Plasma Derivatives Market, by Applications, 2020-2027 (USD Million)

Table 27 Eastern Europe: Blood Plasma Derivatives Market, by End users, 2020-2027 (USD Million)

Table 28 Asia-Pacific: Blood Plasma Derivatives Market, by Type, 2020-2027 (USD Million)

Table 29 Asia-Pacific: Blood Plasma Derivatives Market, by Applications, 2020-2027 (USD Million)

Table 30 Asia-Pacific: Blood Plasma Derivatives Market, by End users, 2020-2027 (USD Million)


Table 31 Middle East & Africa: Blood Plasma Derivatives Market, by Type, 2020-2027 (USD Million)

Table 32 Middle East & Africa: Blood Plasma Derivatives Market, by Applications, 2020-2027 (USD Million)

Table 33 Middle East & Africa: Blood Plasma Derivatives Market, by End users, 2020-2027 (USD Million)  

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Market Structure of the Global Blood Plasma Derivatives Market

Figure 3 Market Dynamics of the Global Blood Plasma Derivatives Market

Figure 5 Global Blood Plasma Derivatives Market, by Type, 2020-2027 (USD Million)

Figure 6 Global Blood Plasma Derivatives Market, by Applications, 2020-2027 (USD Million)

Figure 7 Global Blood Plasma Derivatives Market, by End users, 2020-2027 (USD Million)

Figure 8 Global Blood Plasma Derivatives Market, by Region, 2020-2027 (USD Million)

Figure 9 North America: Blood Plasma Derivatives Market Share, by Country, 2020 (%)

Figure 10 Europe: Blood Plasma Derivatives Market Share, by Region, 2020 (%)

Figure 11 Western Europe: Blood Plasma Derivatives Market Share, by Country, 2020 (%)

Figure 12 Asia-Pacific: Blood Plasma Derivatives Market Share, by Country, 2020 (%)

Figure 13 Middle East & Africa: Blood Plasma Derivatives Market Share, by Country, 2020 (%)

Figure 14 Global Blood Plasma Derivatives Market: Company Share Analysis, 2020 (%)

Figure 15 Baxter BioScience: Key Financial Overview

Figure 16 Baxter BioScience: Segmental Revenue

Figure 17 Baxter BioScience: Geographic Revenue

Figure 18 Grifols S.A.: Key Financial Overview

Figure 19 Grifols S.A.: Segmental Revenue

Figure 20 Grifols S.A.: Geographic Revenue

Figure 21 CSL Behring: Key Financial Overview

Figure 22 CSL Behring: Segmental Revenue

Figure 23 CSL Behring: Geographic Revenue

Figure 24 ViroPharma, Inc.: Key Financial Overview

Figure 25 ViroPharma, Inc.: Segmental Revenue

Figure 26 ViroPharma, Inc.: Geographic Revenue

Figure 27 Talecris Biotherapeutics, Inc.: Key Financial Overview

Figure 28 Talecris Biotherapeutics, Inc.: Segmental Revenue

Figure 29 Talecris Biotherapeutics, Inc.: Geographic Revenue

Figure 30 Octapharma: Key Financial Overview

Figure 31 Octapharma: Segmental Revenue

Figure 32 Octapharma: Geographic Revenue

Figure 33 Fusion Healthcare: Key Financial Overview

Figure 34 Fusion Healthcare: Segmental Revenue

Figure 35 Fusion Healthcare: Geographic Revenue

Figure 36 SK Plasma Co., Ltd.: Key Financial Overview

Figure 37 SK Plasma Co., Ltd.: Segmental Revenue

Figure 38 SK Plasma Co., Ltd.: Geographic Revenue

Figure 39 Biotest AG: Key Financial Overview

Figure 40 Biotest AG: Segmental Revenue

Figure 41 Biotest AG: Geographic Revenue

Figure 42 Green Cross Corporation: Key Financial Overview

Figure 43 Green Cross Corporation: Segmental Revenue

Figure 44 Green Cross Corporation: Geographic Revenue

Figure 45 Shire Plc: Key Financial Overview

Figure 46 Shire Plc: Segmental Revenue

Figure 47 Shire Plc: Geographic Revenue